Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Minnesota |
---|---|
Information provided by: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT00701233 |
To compare local steroid injections to local Botulinum toxin A injection in a double-blinded study. The goal is to investigate if Botulinum toxin A injections are effective for Carpal Tunnel Syndrome compared to steroid injections in terms of pain relief and length of symptom alleviation.
Condition | Intervention |
---|---|
Carpal Tunnel Syndrome |
Drug: Botulinum toxin Drug: Corticosteroid injection into Carpal Tunnel |
Study Type: | Interventional |
Study Design: | Treatment, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Evaluation of Intercarpal Botox Versus Steroid Injections for Carpal Tunnel Syndrome |
Estimated Enrollment: | 20 |
Study Start Date: | June 2008 |
Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
2: Active Comparator
Corticosteroid injection into Carpal Tunnel
|
Drug: Corticosteroid injection into Carpal Tunnel
40 mg Triamcinolone with one mL 1% lidocaine injected once into Carpal Tunnel
|
1: Active Comparator
Botulinum toxin injection into Carpal Tunnel
|
Drug: Botulinum toxin
45 units Botox injected into Carpal Tunnel once
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Phillip J Smith, DO | (612) 625-2661 |
United States, Minnesota | |
University of Minnesota PM&R Department | |
Minneapolis, Minnesota, United States, 55455 |
Responsible Party: | University of Minnesota Physical Medicine and Rehabilitation ( Dennis Dykstra, MD, PhD ) |
Study ID Numbers: | 0708M13705, CTSBotox |
Study First Received: | June 17, 2008 |
Last Updated: | June 17, 2008 |
ClinicalTrials.gov Identifier: | NCT00701233 |
Health Authority: | United States: Food and Drug Administration |
Carpal Tunnel Syndrome Roussy Levy hereditary areflexic dystasia Charcot-Marie-Tooth Disease Lidocaine Wounds and Injuries Disorders of Environmental Origin Triamcinolone diacetate Mononeuropathies Triamcinolone hexacetonide Nerve Compression Syndromes Tomaculous neuropathy |
Botulinum Toxins Triamcinolone Acetonide Neuromuscular Diseases Peripheral Nervous System Diseases Triamcinolone Hereditary Motor and Sensory Neuropathies Botulinum Toxin Type A Charcot Marie Tooth disease Cumulative Trauma Disorders Sprains and Strains |
Median Neuropathy Pathologic Processes Disease Anti-Dyskinesia Agents Therapeutic Uses |
Syndrome Nervous System Diseases Central Nervous System Agents Pharmacologic Actions |